CATO SMS Signs Agreement with InteRNA to Facilitate Phase I Solid Tumor Trial

20 May, 2020

Please click here to read more

NEWS

7 January, 2021

Vacancy for a highly motivated PhD student to join the RnD Research team with a keen interest on “ The endo-lysosomal processes in metabolic disease development and therapeutic efficacy”

6 January, 2021

Klinische Fase 1a studie met onze lead compound INT-1B3

20 May, 2020

CATO SMS Signs Agreement with InteRNA to Facilitate Phase I Solid Tumor Trial

18 May, 2020

Recently a short movie about InteRNA and it’s lead compound for the treatment of cancer was broadcasted in the RTL4/RTLZ program “Zo kan het ook”. Watch the video with the latest news here

6 May, 2020

InteRNA Technologies Receives Regulatory Approval for Initiation of Phase I Clinical Trial of INT-1B3 in Patients with Advanced Solid Tumors

1-5 6-10 11-15 16-20 21-25 26-30 31-35 36-36